Does China’s national volume-based drug procurement policy promote or hinder pharmaceutical innovation?

IntroductionThe national volume-based drug procurement policy initiated in China since 2018 represents a significant reform in China’s pharmaceutical distribution system. It has largely squeezed out the price bubble of low-end generic drugs, making competition in the pharmaceutical sales segment mor...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Xiujuan Li, Jiachun Xu
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2024-06-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	China’s national volume-based drug procurement policy innovation input innovation output quantity innovation output quality multi-period DID
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1392239/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!